IGC (STOCKS)
IGC Pharma, Inc.
$0.300900
-0.001000 (-0.33%)
Prev close: $0.301900
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ram Mukunda
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28.94M
- Employees
- 70
- P/E (TTM)
- -4.81
- P/B (TTM)
- 3.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.11M |
| Benefits Costs and Expenses | $7.55M |
| Cost Of Revenue | $595.00K |
| Costs And Expenses | $7.55M |
| Gross Profit | $511.00K |
| Operating Expenses | $8.61M |
| Selling, General, and Administrative Expenses | $4.32M |
| Research and Development | $4.29M |
| Operating Income/Loss | -$8.09M |
| Income/Loss From Continuing Operations After Tax | -$6.45M |
| Income/Loss From Continuing Operations Before Tax | -$6.45M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$6.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $1.00K |
| Net Income/Loss Attributable To Parent | -$6.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 88,860,932 |
| Diluted Average Shares | 88,860,932 |
| Assets | $9.74M |
| Current Assets | $2.00M |
| Inventory | $658.00K |
| Other Current Assets | $1.35M |
| Noncurrent Assets | $7.74M |
| Fixed Assets | $2.18M |
| Intangible Assets | $4.88M |
| Other Non-current Assets | $685.00K |
| Liabilities | $1.65M |
| Current Liabilities | $1.51M |
| Accounts Payable | $628.00K |
| Wages | $398.00K |
| Other Current Liabilities | $488.00K |
| Noncurrent Liabilities | $137.00K |
| Commitments and Contingencies | $0.00 |
| Equity | $8.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.09M |
| Liabilities And Equity | $9.74M |
| Net Cash Flow From Operating Activities | -$5.54M |
| Net Cash Flow From Operating Activities, Continuing | -$5.54M |
| Net Cash Flow From Investing Activities | -$40.00K |
| Net Cash Flow From Investing Activities, Continuing | -$40.00K |
| Net Cash Flow From Financing Activities | $5.11M |
| Net Cash Flow From Financing Activities, Continuing | $5.11M |
| Net Cash Flow | -$473.00K |
| Net Cash Flow, Continuing | -$473.00K |
| Comprehensive Income/Loss | -$6.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.48M |
| Other Comprehensive Income/Loss | -$34.00K |